Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-04-18

Clinical Trial Update: Mechanistic Effects of Colchicine in Patients With Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating mechanistic effects of colchicine in myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: NYU Langone Health | Conditions: Myocardial Infarction | Phase 4 | Status: WITHDRAWN